These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16177257)

  • 1. Sudden death in patients with myocardial infarction.
    Pitt B;
    N Engl J Med; 2005 Sep; 353(12):1294-7; author reply 1294-7. PubMed ID: 16177257
    [No Abstract]   [Full Text] [Related]  

  • 2. Eplerenone in patients with left ventricular dysfunction.
    Coca SG; Buller GK
    N Engl J Med; 2003 Jul; 349(1):88-9; author reply 88-9. PubMed ID: 12846223
    [No Abstract]   [Full Text] [Related]  

  • 3. [Selective aldosterone blocking in heart failure. Eplerenone reduces the risk after infarction].
    MMW Fortschr Med; 2003 Oct; 145(44):42-3. PubMed ID: 14655506
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials.
    Rossello X; Ariti C; Pocock SJ; Ferreira JP; Girerd N; McMurray JJV; Van Veldhuisen DJ; Pitt B; Zannad F
    Clin Res Cardiol; 2019 May; 108(5):477-486. PubMed ID: 30264282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pfizer launches Inspra for heart failure.
    Cardiovasc J S Afr; 2006; 17(4):220. PubMed ID: 17001435
    [No Abstract]   [Full Text] [Related]  

  • 6. Late breaking heart failure trials from the 2003 ACC meeting: EPHESUS and COMPANION.
    Teerlink JR; Massie BM;
    J Card Fail; 2003 Jun; 9(3):158-63. PubMed ID: 12815564
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?
    van der Horst IC; Voors AA; van Veldhuisen DJ
    Clin Res Cardiol; 2007 Apr; 96(4):193-5. PubMed ID: 17294352
    [No Abstract]   [Full Text] [Related]  

  • 8. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
    Pitt B; Remme W; Zannad F; Neaton J; Martinez F; Roniker B; Bittman R; Hurley S; Kleiman J; Gatlin M;
    N Engl J Med; 2003 Apr; 348(14):1309-21. PubMed ID: 12668699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone blockade in patients with systolic left ventricular dysfunction.
    Pitt B
    Circulation; 2003 Oct; 108(15):1790-4. PubMed ID: 14557343
    [No Abstract]   [Full Text] [Related]  

  • 10. Sudden death in patients with myocardial infarction.
    Khera A; Levine BD
    N Engl J Med; 2005 Sep; 353(12):1294-7; author reply 1294-7. PubMed ID: 16180270
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of heart failure and left ventricular systolic dysfunction following acute myocardial infarction.
    Conti CR
    Clin Cardiol; 2005 Jan; 28(1):1-2. PubMed ID: 15704523
    [No Abstract]   [Full Text] [Related]  

  • 12. Should the aldosterone-receptor antagonist - eplerenone - be used after acute myocardial infarction with left ventricular dysfunction?
    Doggrell S
    Expert Opin Pharmacother; 2003 Sep; 4(9):1605-7. PubMed ID: 12943490
    [No Abstract]   [Full Text] [Related]  

  • 13. Adherence to aldosterone-blocking agents in patients with heart failure.
    Margolis J; Gerber RA; Roberts C; Gheorghiade M
    Am J Ther; 2010; 17(5):446-54. PubMed ID: 20844344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
    Solomon SD; Zelenkofske S; McMurray JJ; Finn PV; Velazquez E; Ertl G; Harsanyi A; Rouleau JL; Maggioni A; Kober L; White H; Van de Werf F; Pieper K; Califf RM; Pfeffer MA;
    N Engl J Med; 2005 Jun; 352(25):2581-8. PubMed ID: 15972864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden death in patients with myocardial infarction.
    Zijlstra F; van der Horst IC
    N Engl J Med; 2005 Sep; 353(12):1294-7; author reply 1294-7. PubMed ID: 16180271
    [No Abstract]   [Full Text] [Related]  

  • 16. Sudden death after myocardial infarction--who needs prophylaxis, and when?
    Buxton AE
    N Engl J Med; 2005 Jun; 352(25):2638-40. PubMed ID: 15972871
    [No Abstract]   [Full Text] [Related]  

  • 17. Aldosterone blockade and heart failure.
    Jessup M
    N Engl J Med; 2003 Apr; 348(14):1380-2. PubMed ID: 12668698
    [No Abstract]   [Full Text] [Related]  

  • 18. Sudden death in patients with myocardial infarction.
    Jacobs AG
    N Engl J Med; 2005 Sep; 353(12):1294-7; author reply 1294-7. PubMed ID: 16180269
    [No Abstract]   [Full Text] [Related]  

  • 19. Eplerenone in patients with left ventricular dysfunction.
    Aggarwal A
    N Engl J Med; 2003 Jul; 349(1):88-9; author reply 88-9. PubMed ID: 12840098
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
    MMW Fortschr Med; 2005 Jul; 147(27-28):44. PubMed ID: 16041942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.